November 3, 2005
Follettie MT et al. Endocrinology 2006;147:714-723.
Organ Messenger Ribonucleic Acid and Plasma Proteome Changes in the Adjuvant-Induced Arthritis Model: Responses to Disease Induction and Therapy With the Estrogen Receptor-Beta Selective Agonist ERB-041
You might also be interested by
Posters
Can Microsampling Devices Coupled with Intact Mass High-Resolution Mass Spectrometry Improve M-Protein Monitoring and Simplify Minimal Residual Disease Assessment in Multiple Myeloma?
November 10, 2025
Proteomics/Mass Spectrometry
More infoWeb News
CellCarta Expands Proteomics Offering with Olink® Reveal Assay
August 6, 2025
Proteomics/Mass Spectrometry
More infoBrochures & Infographics
Supporting Your Targeted Protein Degradation Strategies
April 1, 2025
Proteomics/Mass Spectrometry
More infoWeb News
CellCarta Joins Olink™ Certified Service Provider Network in China
February 13, 2025
Proteomics/Mass Spectrometry
More info